Pathway Financial Advisers’s Smith & Wesson SWBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-520
Closed -$6.74K 442
2024
Q3
$6.74K Buy
520
+4
+0.8% +$58 ﹤0.01% 316
2024
Q2
$7.39K Buy
516
+5
+1% +$82 ﹤0.01% 366
2024
Q1
$8.88K Buy
511
+4
+0.8% +$58 ﹤0.01% 358
2023
Q4
$6.88K Buy
507
+4
+0.8% +$55 ﹤0.01% 388
2023
Q3
$6.49K Buy
+503
New +$6.28K ﹤0.01% 399
2023
Q1
$15K Buy
1,220
+24
+2% +$257 0.01% 335
2022
Q4
$10.4K Buy
+1,196
New +$12.6K ﹤0.01% 418

Other funds holding SWBI

Pathway Financial Advisers's SWBI Position: Q4 2024 in Review

Pathway Financial Advisers sold out of Smith & Wesson (SWBI) in Q4 2024, closing a stake of 520 shares — an estimated $6.74K sold.

Pathway Financial Advisers first reported a position in SWBI in Q4 2022 and held it in 7 quarters. The position peaked at $15K in Q1 2023. 182 funds tracked by Wall St. Rank hold SWBI as of Q4 2024.

  • Pathway Financial Advisers reported no remaining Smith & Wesson position as of Q4 2024 after selling out during the quarter.
  • Pathway Financial Advisers sold 520 Smith & Wesson shares in Q4 2024, an estimated $6.74K.
  • Pathway Financial Advisers first reported a position in Smith & Wesson in Q4 2022 and held it in 7 quarters.
  • Pathway Financial Advisers's Smith & Wesson position peaked at $15K in Q1 2023.
  • 182 funds tracked by Wall St. Rank held Smith & Wesson as of Q4 2024.

Based on Pathway Financial Advisers's 13F filing for Q4 2024, filed 30 Jan 2025.